Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

Redmond, founder and CEO of Dr. Stephanie’s Supplements, showcased her products, which she described as the latest innovations in supplement options for hormone and metabolic health, including a ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.

Several DPP-4 inhibitors are in clinical development; these are orally active and increase levels of active GLP-1, which in turn increases insulin secretion and reduces glucagon secretion and ...

Objective—Glucagon-like peptide 1 (GLP-1 ... while the inhibition of α-cell secretion has received less attention. The aim of this research was to quantify the glucagonostatic contribution ...

Life Sciences Ontario (LSO) proudly announces the recipients of the 2025 LSO Awards, celebrating excellence and innovation in life sciences. Now in its 22nd year, the LSO Awards continues its ...

For years, obesity was often seen as a result of poor lifestyle choices. However, experts now suggest that biological factors ...

Gallstones are broadly classified into 2 major types: cholesterol stones and pigment stones, with the former type being the most common. 5 They can develop either in the gallbladder or in the bile ...